UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.122

Sortiert nach

Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer

The Journal of clinical investigation, 2010-07, Vol.120 (7), p.2406-2413

2010

Link zum Volltext

Verfügbarkeit prüfen

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

Nature medicine, 2012-07, Vol.18 (7), p.1052-1059

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy

Journal of clinical oncology, 2012-09, Vol.30 (26), p.3287-3296

2012

Link zum Volltext

Verfügbarkeit prüfen

Metformin: A Therapeutic Opportunity in Breast Cancer

Clinical cancer research, 2010-03, Vol.16 (6), p.1695-1700

2010

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Phosphatidylinositol 3‐Kinase Signaling Pathway in Breast Cancer

The oncologist (Dayton, Ohio), 2011-01, Vol.16 (4), p.404-414

2011

Link zum Volltext

Verfügbarkeit prüfen

Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer

Clinical cancer research, 2013-07, Vol.19 (13), p.3703-3713

2013

Link zum Volltext

Verfügbarkeit prüfen

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2016-04, Vol.34 (10), p.1134-1150

2016

Link zum Volltext

Verfügbarkeit prüfen

Rax regulates hypothalamic tanycyte differentiation and barrier function in mice

Journal of comparative neurology (1911), 2014-03, Vol.522 (4), p.876-899

2014

Link zum Volltext

Verfügbarkeit prüfen

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

Journal of clinical oncology, 2012-02, Vol.30 (6), p.593-599

2012

Link zum Volltext

Verfügbarkeit prüfen

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

Journal of clinical oncology, 2008-03, Vol.26 (8), p.1275-1281

2008

Link zum Volltext

Verfügbarkeit prüfen

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

Journal of clinical oncology, 2011-07, Vol.29 (19), p.2645-2652

2011

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 expression in triple-negative breast cancer

Cancer immunology research, 2014-04, Vol.2 (4), p.361-370

2014

Link zum Volltext

Verfügbarkeit prüfen

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3297-3302

2009

Link zum Volltext

Verfügbarkeit prüfen

Future of Personalized Medicine in Oncology: A Systems Biology Approach

Journal of clinical oncology, 2010-06, Vol.28 (16), p.2777-2783

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer

Cancer, 2012-03, Vol.118 (5), p.1202-1211

2012

Link zum Volltext

Verfügbarkeit prüfen

Sympathovagal quotient and resting-state functional connectivity of control networks are related to gut Ruminococcaceae abundance in healthy men

Psychoneuroendocrinology, 2024-06, Vol.164, p.107003-107003, Article 107003

2024

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4116-4124

2009

Link zum Volltext

Verfügbarkeit prüfen

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2015-08, Vol.33 (24), p.2695-2704

2015

Link zum Volltext

Verfügbarkeit prüfen

High ERK Protein Expression Levels Correlate with Shorter Survival in Triple‐Negative Breast Cancer Patients

The oncologist (Dayton, Ohio), 2012-06, Vol.17 (6), p.766-774

2012

Link zum Volltext

Verfügbarkeit prüfen

PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer

Molecular cancer therapeutics, 2011-06, Vol.10 (6), p.1093-1101

2011

Link zum Volltext

Verfügbarkeit prüfen

Microglia modulate respiratory rhythm generation and autoresuscitation

Glia, 2016-04, Vol.64 (4), p.603-619

2016

Link zum Volltext

Verfügbarkeit prüfen

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2014-07, Vol.32 (19), p.2078-2099

2014

Link zum Volltext

Verfügbarkeit prüfen

A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance

Clinical cancer research, 2011-04, Vol.17 (7), p.2024-2034

2011

Link zum Volltext

Verfügbarkeit prüfen

Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy

Breast cancer research : BCR, 2012-05, Vol.14 (3), p.R83-R83, Article R83

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer

Journal of clinical oncology, 2014-03, Vol.32 (8), p.735-744

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(992)
Mit Volltextzugriff
(1.061)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(75)
Cancer
(45)
Cancer Research
(31)
Journal Of Virology
(30)
Clinical Cancer Research
(26)
Plos One
(22)
Clinical Breast Cancer
(19)
The Oncologist
(15)
Revista Científica
(13)
Breast Cancer Research And Treatment
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy

Metformin: A Therapeutic Opportunity in Breast Cancer

Targeting the Phosphatidylinositol 3‐Kinase Signaling Pathway in Breast Cancer

Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Rax regulates hypothalamic tanycyte differentiation and barrier function in mice

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

PD-L1 expression in triple-negative breast cancer

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

Future of Personalized Medicine in Oncology: A Systems Biology Approach

Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer

Sympathovagal quotient and resting-state functional connectivity of control networks are related to gut Ruminococcaceae abundance in healthy men

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

High ERK Protein Expression Levels Correlate with Shorter Survival in Triple‐Negative Breast Cancer Patients

PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer

Microglia modulate respiratory rhythm generation and autoresuscitation

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance

Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy

Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer

Suchergebnisse filtern